Send this to a friend

CardioFocus begins clinical trials on atrial fibrillation device

Marlborough medical device manufacturer CardioFocus, Inc. has begun clinical trials of a new system to treat atrial fibrillation.
The HeartLight X3 System, according to the company’s announcement Monday, features many of the same technologies of the company’s previous devices, but is designed to deliver rapid, continuous, 360-degree lesions.
According to CardioFocus, the device treats atrial fibrillat ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media